Education
About Us
Working with TipRanks
Follow Us
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
ASBP Stock Chart & Stats
$2.13
--
Market closed
$2.13
--
Day’s Range― - ―
52-Week Range$1.41 - $632.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)27.58M
Market Cap
$7.37M
Enterprise Value$6.81M
Total Cash (Recent Filing)$1.95M
Total Debt (Recent Filing)$1.38M
Price to Earnings (P/E)―
Beta2.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.56
Shares Outstanding3,461,153
10 Day Avg. Volume3,584,512
30 Day Avg. Volume27,577,381
Financial Highlights & Ratios
PEG Ratio1.59
Price to Book (P/B)-9.85K
Price to Sales (P/S)0.00
P/FCF Ratio-57.20K
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue3.51K
Enterprise Value/Gross Profit7.70K
Enterprise Value/Ebitda-0.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aspire Biopharma Holdings News
ASBP FAQ
What was Aspire Biopharma Holdings’s price range in the past 12 months?
Aspire Biopharma Holdings lowest stock price was $1.41 and its highest was $632.00 in the past 12 months.
What is Aspire Biopharma Holdings’s market cap?
Aspire Biopharma Holdings’s market cap is $7.37M.
When is Aspire Biopharma Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aspire Biopharma Holdings’s earnings last quarter?
Currently, no data Available
Is Aspire Biopharma Holdings overvalued?
According to Wall Street analysts Aspire Biopharma Holdings’s price is currently Overvalued.
Does Aspire Biopharma Holdings pay dividends?
Aspire Biopharma Holdings does not currently pay dividends.
What is Aspire Biopharma Holdings’s EPS estimate?
Aspire Biopharma Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aspire Biopharma Holdings have?
Aspire Biopharma Holdings has 3,461,153 shares outstanding.
What happened to Aspire Biopharma Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aspire Biopharma Holdings?
Currently, no hedge funds are holding shares in ASBP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Technical Analysis
Ownership Overview
0.58% Insiders
14.14% Mutual Funds
― Other Institutional Investors
76.20% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---